604 related articles for article (PubMed ID: 28283847)
1. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
[TBL] [Abstract][Full Text] [Related]
2. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
[TBL] [Abstract][Full Text] [Related]
3. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality.
Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V;
Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471
[TBL] [Abstract][Full Text] [Related]
4. Impact of diabetes on the predictive value of heart failure biomarkers.
Alonso N; Lupón J; Barallat J; de Antonio M; Domingo M; Zamora E; Moliner P; Galán A; Santesmases J; Pastor C; Mauricio D; Bayes-Genis A
Cardiovasc Diabetol; 2016 Nov; 15(1):151. PubMed ID: 27809845
[TBL] [Abstract][Full Text] [Related]
5. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease: Results of the KAROLA Study.
Jansen H; Koenig W; Jaensch A; Mons U; Breitling LP; Scharnagl H; Stojakovic T; Schunkert H; Brenner H; Rothenbacher D
Clin Chem; 2016 Oct; 62(10):1372-9. PubMed ID: 27540030
[TBL] [Abstract][Full Text] [Related]
7. Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study.
Jansen H; Jänsch A; Breitling LP; Hoppe L; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
Int J Cardiol; 2018 Jan; 250():247-252. PubMed ID: 29169757
[TBL] [Abstract][Full Text] [Related]
8. Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study.
Wang Z; Chen Z; Yu H; Ma X; Zhang C; Qu B; Zhang W; Chen X
Ren Fail; 2020 Nov; 42(1):523-530. PubMed ID: 32460670
[No Abstract] [Full Text] [Related]
9. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.
Koenig W; Breitling LP; Hahmann H; Wüsten B; Brenner H; Rothenbacher D
Clin Chem; 2012 Aug; 58(8):1215-24. PubMed ID: 22634379
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of soluble suppression of tumorigenesis-2 (sST2) for cardiovascular events in coronary artery disease patients with and without diabetes mellitus.
Li M; Duan L; Cai Y; Hao B; Chen J; Li H; Liu H
Cardiovasc Diabetol; 2021 Feb; 20(1):49. PubMed ID: 33608010
[TBL] [Abstract][Full Text] [Related]
12. Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
Yu J; Oh PC; Kim M; Moon J; Park YM; Lee K; Suh SY; Han SH; Byun K; Ahn T; Kang WC
PLoS One; 2017; 12(8):e0182829. PubMed ID: 28796845
[TBL] [Abstract][Full Text] [Related]
13. IL1RL1 single nucleotide polymorphism predicts sST2 level and mortality in coronary and peripheral artery disease.
Lin JF; Wu S; Juang JJ; Chiang FT; Hsu LA; Teng MS; Cheng ST; Huang HL; Sun YC; Liu PY; Ko YL
Atherosclerosis; 2017 Feb; 257():71-77. PubMed ID: 28110258
[TBL] [Abstract][Full Text] [Related]
14. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
Bai J; Han L; Liu H
Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
[TBL] [Abstract][Full Text] [Related]
15. NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.
Niccoli G; Conte M; Marchitti S; Montone RA; Fracassi F; Grippo R; Roberto M; Burzotta F; Trani C; Leone AM; Bianchi F; Di Castro S; Volpe M; Crea F; Rubattu S
Cardiovasc Revasc Med; 2016; 17(3):162-8. PubMed ID: 26987266
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
[TBL] [Abstract][Full Text] [Related]
17. Increased Soluble Suppression of Tumorigenicity 2 Level Predicts All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients: A Prospective Cohort Study.
Zhang Z; Shen B; Cao X; Liu Z; Chen X; Nie Y; Yu J; Zou J; Ding X
Blood Purif; 2017; 43(1-3):37-45. PubMed ID: 27875808
[TBL] [Abstract][Full Text] [Related]
18. Multiple marker approach to risk stratification in patients with stable coronary artery disease.
Schnabel RB; Schulz A; Messow CM; Lubos E; Wild PS; Zeller T; Sinning CR; Rupprecht HJ; Bickel C; Peetz D; Cambien F; Kempf T; Wollert KC; Benjamin EJ; Lackner KJ; Münzel TF; Tiret L; Vasan RS; Blankenberg S
Eur Heart J; 2010 Dec; 31(24):3024-31. PubMed ID: 20852293
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
[TBL] [Abstract][Full Text] [Related]
20. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
